-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – arfolitixorin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry arfolitixorin Drug Details Arfolitixorin (modufolin) is under development for the treatment of osteosarcoma. It...
-
Product Insights
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteosarcoma is the most common cancer of the bone that destroys tissue and weakens the bone. It is developed from immature bone cells that normally form new bone tissue. Osteosarcoma Drugs in Development market research report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research...
-
Sector Analysis
North America Other Joint Reconstruction Market Size (Value, Volume, ASP) by Segments (Ankle Replacement, Digits Replacement, Elbow Replacement and Wrist Replacement), Share and Forecast, 2015-2025
GlobalData’s “North America Other Joint Reconstruction Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Other Joint Reconstruction market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Ankle Replacement, Digits Replacement, Elbow Replacement and Wrist Replacement. The North America Other Joint Reconstruction Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each...
-
Sector Analysis
North America Orthobiologics Market Size (Value, Volume, ASP) by Segments (Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others), Share and Forecast, 2015-2025
GlobalData’s “North America Orthobiologics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair, Soft Tissue Biologics and Viscosupplementation. The North America Orthobiologics Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of...
-
Sector Analysis
Colorectal Cancer – Global Drug Forecast and Market Analysis to 2028
Colorectal cancer (CRC) occurs in the large intestine or large bowel. It is the third most common cancer globally and is one of the most common causes of cancer deaths in the world. Early stage CRC is commonly treated with surgery, while metastatic colorectal cancer (mCRC) treatment is dominated by fluorouracil chemotherapy regimens in combination with angiogenesis inhibitors, primarily Roche’s Avastin, and epidermal growth factor receptor (EGFR) inhibitors. GlobalData valued the CRC market at $7.6B in 2018. This market is...